Company Filing History:
4 out of 4 
1 out of 2 
1 out of 5 Years Active: 1999-2012
Title: The Innovative Contributions of Jean-Pierre Salles
Introduction
Jean-Pierre Salles is a notable inventor based in Eguilles, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds and delivery systems aimed at treating oxidative stress-related diseases. With a total of 5 patents to his name, Salles continues to push the boundaries of innovation in his field.
Latest Patents
Among his latest patents, Salles has developed compounds derived from α-C-phenyl-N-tert-butylnitrone. This invention focuses on a process for the preparation of these compounds and their use in creating medicaments for preventing or treating oxidative stress-related diseases. Another significant patent involves a liposomal vector for active principles. This invention concerns liposome vectors in powder form, designed to protect sensitive active principles, such as proteins, from degradation. The liposomes consist of unilamellar structures with specific lipid compositions and gelling agents, ensuring effective delivery of medicinal compounds.
Career Highlights
Throughout his career, Jean-Pierre Salles has worked with various companies, including Lipogel and Ts Pharma. His work has been instrumental in advancing the development of innovative pharmaceutical solutions. His expertise in medicinal chemistry has allowed him to create formulations that enhance the efficacy of active ingredients.
Collaborations
Salles has collaborated with notable professionals in his field, including Grégory Durand and Ange Polidori. These collaborations have contributed to the successful development of his patented inventions and have fostered a spirit of innovation in the pharmaceutical industry.
Conclusion
Jean-Pierre Salles is a distinguished inventor whose work has significantly impacted the field of medicinal chemistry. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions. His contributions continue to pave the way for future developments in the treatment of oxidative stress-related diseases.